"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

These results show a strong correlation between patient- and physician-reported measures and the promise of esketamine ...

Research presented at this year's Psych Congress meeting in Boston included a randomized trial of esketamine (Spravato) ...

it is important that ketamine treatment be administered in a medically supervised setting. Esketamine is currently FDA-indicated as an adjunctive treatment after two failed antidepressant trials.

Roy Perlis is the director of the Center for Quantitative Health at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School. Stephen Morrissey, the interviewer, is ...

In contrast, esketamine targets glutamate ... "I have no doubt in my mind that this is a very useful treatment," Gerard Sanacora, a psychiatrist and the director of the Yale Depression Research ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Brain and Cognition Discovery Foundation, Toronto, ON, Canada Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Department of Pharmacology & Toxicology, University ...

Relevance is one of the only facilities that offer Spravato (esketamine) treatment for major depressive disorder, which can be covered by most insurance carriers. Choose Relevance Behavioral ...

Currently accepting new clients for Spravato (Esketamine) treatment! I have been a Board Certified Psychiatric Nurse Practitioner for five years, working in Bangor Maine for the bulk of that time.